by Harry G. Brittain (Author)
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 45, presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. The series encompasses review articles, with this release focusing on Azilsartan Medoxomil, Piroxicam, Carbetapentane Citrate, Emtricitabine, Etrlotinib, Isotretinoin and Meloxicam.
Contains contributions from leading authorities Informs and updates on all the latest developments in the field of drug substances, excipients and methodologies
Product Details
Publisher: Elsevier Science; March 10, 2020
Language: English
ISBN: 9780128203231
ISBN: 9780128203248

History of Infectious Disease Pandemics in Urban Societies
Stem Cells: New Frontiers in Science & Ethics
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th Edition
Arbeitgeber Patient – Kundenorientierung in Gesundheitsberufen
Lippincott's Concise Illustrated Anatomy: Volume 2: Thorax, Abdomen & Pelvis
Medicines, Ethics and Practice: The Professional Guide for Pharmacists
Supporting Sucking Skills In Breastfeeding Infants 2nd
Safety Concerns for Herbal Drugs
Renal Physiology: A Clinical Approach (Integrated Physiology Series)
Telemedicine and Electronic Medicine
Dynamic Ophthalmic Ultrasonography: A Video Atlas for Ophthalmologists and Imaging Technicians (PDF)
Pharmacology of Ocular Therapeutics (PDF)
Small Animal Soft Tissue Surgery
Lippincott's Concise Illustrated Anatomy: Volume 1: Back, Upper Limb and Lower Limb
Sexually Transmitted Infections: Diagnosis, Management, and Treatment
Integrative Therapies for Depression: Redefining Models for Assessment, Treatment and Prevention
Lippincott's Concise Illustrated Anatomy: Volume 3: Head & Neck
Field Guide to Wilderness Medicine 4th
Anatomy of Neuropsychiatry: The New Anatomy of the Basal Forebrain and Its Implications for Neuropsychiatric Illness 1st Edition 


Reviews
There are no reviews yet.